Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Experimental Neurology

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.expneurol.2008.12.007PMID 19146854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving Outcome after Stroke: Overcoming the Translational Roadblock

  2008cited by this paper
• Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved

  2007cited by this paper
• PPAR-gamma: therapeutic target for ischemic stroke.

  2007cited by this paper
• Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

  2007cited by this paper
• The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.

  2007cited by this paper
• The PPAR-γ agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells

  2007cited by this paper
• PPAR-γ: therapeutic target for ischemic stroke

  2007cited by this paper
• The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury.

  2007cited by this paper
• Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)

  2007cited by this paper
• Altered PPARgamma expression and activation after transient focal ischemia in rats.

  2006cited by this paper
• Altered PPARγ expression and activation after transient focal ischemia in rats

  2006cited by this paper
• Bench to Bedside: The Quest for Quality in Experimental Stroke Research

  2006cited by this paper
• Nicotinamide Protects against Ethanol-Induced Apoptotic Neurodegeneration in the Developing Mouse Brain

  2006cited by this paper
• Physical Activity Improves Long-Term Stroke Outcome via Endothelial Nitric Oxide Synthase–Dependent Augmentation of Neovascularization and Cerebral Blood Flow

  2006cited by this paper
• Peroxisome-proliferator-activated receptor-gamma (PPARγ) activation protects neurons from NMDA excitotoxicity

  2006cited by this paper
• Neuroprotection against focal ischemic brain injury by the peroxisome proliferator‐activated receptor‐γ agonist rosiglitazone

  2006cited by this paper
• Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion.

  2006cited by this paper
• Therapeutic strategies for the treatment of stroke.

  2006cited by this paper
• 15d-Prostaglandin J2 Activates Peroxisome Proliferator-Activated Receptor-γ, Promotes Expression of Catalase, and Reduces Inflammation, Behavioral Dysfunction, and Neuronal Loss after Intracerebral Hemorrhage in Rats

  2006cited by this paper
• Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat.

  2006cited by this paper
• Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia

  2005cited by this paper
• A Peroxisome Proliferator-Activated Receptor-&ggr; Agonist Reduces Infarct Size in Transient but Not in Permanent Ischemia

  2005cited by this paper
• Nuclear receptor peroxisome proliferator‐activated receptor‐γ is activated in rat microglial cells by the anti‐inflammatory drug HCT1026, a derivative of flurbiprofen

  2005cited by this paper
• Systemic inflammation induces apoptosis with variable vulnerability of different brain regions.

  2005cited by this paper
• The Nonthiazolidinedione PPARγ Agonist L-796,449 Is Neuroprotective in Experimental Stroke

  2005cited by this paper
• Anxious and hyperactive phenotype following brief ischemic episodes in mice.

  2005cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis

  2005cited by this paper
• 15d-Prostaglandin J2 Protects Brain From Ischemia-Reperfusion Injury

  2005cited by this paper
• The Oral Antidiabetic Pioglitazone Protects from Neurodegeneration and Amyotrophic Lateral Sclerosis-Like Symptoms in Superoxide Dismutase-G93A Transgenic Mice

  2005cited by this paper
• The intracerebral application of the PPARγ‐ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain

  2005cited by this paper
• Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.

  2005cited by this paper
• Targeting eNOS for stroke protection.

  2004cited by this paper
• Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

  2004cited by this paper
• Hypoxia-Ischemia Induces DNA Synthesis without Cell Proliferation in Dying Neurons in Adult Rodent Brain

  2004cited by this paper
• Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

  2004cited by this paper
• PPAR γ activators induce growth arrest and process extension in B12 oligodendrocyte‐like cells and terminal differentiation of cultured oligodendrocytes

  2003cited by this paper
• Dysexecutive Syndrome After Mild Cerebral Ischemia?: Mice Learn Normally but Have Deficits in Strategy Switching

  2003cited by this paper
• Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation

  2003cited by this paper
• Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease

  2002cited by this paper
• Impaired Spatial Performance in Rats with Retrosplenial Lesions: Importance of the Spatial Problem and the Rat Strain in Identifying Lesion Effects in a Swimming Pool

  2002cited by this paper
• Fischer 344 and wistar rats differ in anxiety and habituation but not in water maze performance.

  2002cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.

  2002cited by this paper
• Peroxisome proliferator‐activated receptor‐γ agonists prevent experimental autoimmune encephalomyelitis

  2002cited by this paper
• Mild Cerebral Ischemia Induces Loss of Cyclin-Dependent Kinase Inhibitors and Activation of Cell Cycle Machinery before Delayed Neuronal Cell Death

  2001cited by this paper
• Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma.

  2001cited by this paper
• Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease.

  2001cited by this paper
• Role of tumor necrosis factor-α in neuronal and glial apoptosis after spinal cord injury

  2000cited by this paper
• DNA Methyltransferase Contributes to Delayed Ischemic Brain Injury

  2000cited by this paper
• Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury.

  2000cited by this paper
• Microglial activation by components of gram-positive and -negative bacteria: distinct and common routes to the induction of ion channels and cytokines.

  1999cited by this paper
• Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

  1999cited by this paper
• Neuroprotective effects of gelsolin during murine stroke.

  1999cited by this paper
• Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis.

  1998cited by this paper
• PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

  1998cited by this paper
• Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

  1998cited by this paper
• The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

  1998cited by this paper
• Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

  1998cited by this paper
• PPAR-γ agonists inhibit production of monocyte inflammatory cytokines

  1998cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.

  1997cited by this paper
• Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion.

  1997cited by this paper
• Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton.

  1996cited by this paper
• Production of tumor necrosis factor in spinal cord following traumatic injury in rats.

  1996cited by this paper
• Inhibition of growth‐factor‐activated proliferation by anti‐estrogens and effects on early gene expression of mcf‐7 cells

  1993cited by this paper
• A Semiautomated Method for Measuring Brain Infarct Volume

  1990cited by this paper
• The FASEB Journal • Research Communication Activation of cerebral peroxisome proliferator-activated

  year unknowncited by this paper

• Multicolor fate mapping of microglia reveals polyclonal proliferation, heterogeneity, and cell-cell interactions after ischemic stroke in mice

  2025cites this paper
• Metformin Inhibits Microglial Activation-Mediated Cuproptosis by Modulating the TLR4/Myd88/NF-κB Signaling Pathway in Parkinson’s Disease

  2025cites this paper
• Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

  2025cites this paper
• Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis, in silico evaluation, PPAR-γ binding assay and transactivation and expression studies

  2024cites this paper
• Intra‐Arterial Deoxyribonuclease Therapy Improves Stroke Outcomes in Aged Mice

  2024cites this paper
• Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke.

  2024cites this paper
• Advancing Post-Stroke Depression Research: Insights from Murine Models and Behavioral Analyses

  2024cites this paper
• Daidzein’s potential in halting neurodegeneration: unveiling mechanistic insights

  2024cites this paper
• Potential role of IGF-1/GLP-1 signaling activation in intracerebral hemorrhage

  2022cites this paper
• Regulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes

  2022cites this paper
• Apremilast exerts protective effects on stroke outcomes and blood–brain barrier (BBB) dysfunction through regulating Rho‐associated protein kinase 2 expression

  2022cites this paper
• Biological Implications of a Stroke Therapy Based in Neuroglobin Hyaluronate Nanoparticles. Neuroprotective Role and Molecular Bases

  2021cites this paper
• Rosiglitazone Protects Blood-Brain Barrier Integrity Following Ischemic Stroke by Reducing MMP-9 Expression Through a Caveolin-1-Dependent Pathway.

  2020cites this paper
• Two Rationally Identified Novel Glitazones Reversed the Behavioral Dysfunctions and Exhibited Neuroprotection Through Ameliorating Brain Cytokines and Oxy-Radicals in ICV-LPS Neuroinflammatory Rat Model

  2020cites this paper
• Hyaluronate Nanoparticles as a Delivery System to Carry Neuroglobin to the Brain after Stroke

  2020cites this paper
• Behavioral tests in rodent models of stroke.

  2020cites this paper
• Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice

  2019cites this paper
• Synthesis and characterization of different sodium hyaluronate nanoparticles to transport large neurotherapheutic molecules through blood brain barrier after stroke

  2019cites this paper
• Chemogenetic activation of glutamatergic neurons in the motor cortex promotes functional recovery after ischemic stroke in rats

  2019cites this paper
• Systemische Behandlung mit Pioglitazon nach fokaler zerebraler Ischämie: Eine präklinische Studie an Ratten

  2019cites this paper
• Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes

  2019cites this paper
• Effect of G-CSF on the spatial arrangement of CA1 hippocampal pyramidal neurons after brain ischemia in the male rats.

  2019cites this paper
• Interferon regulatory factor 4/5 signaling impacts on microglial activation after ischemic stroke in mice

  2018cites this paper
• Distinguishing features of microglia- and monocyte-derived macrophages after stroke

  2018cites this paper
• Inflammatory Responses are Sex Specific in Chronic Hypoxic–Ischemic Encephalopathy

  2018cites this paper
• Pioglitazone reduces mortality, prevents depressive‐like behavior, and impacts hippocampal neurogenesis in the 6‐OHDA model of Parkinson's disease in rats

  2018cites this paper
• Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation

  2017cites this paper
• Stroke, Cognitive Function, and Alzheimer’s Disease

  2016cites this paper
• Method parameters’ impact on mortality and variability in mouse stroke experiments: a meta-analysis

  2016cites this paper
• Autophagy in Diabetic Retinopathy

  2016cites this paper
• The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes

  2016cites this paper
• Conventional protein kinase Cβ‐mediated phosphorylation inhibits collapsin response‐mediated protein 2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke‐induced mice

  2016cites this paper
• Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders.

  2016cites this paper
• Alpha-linolenic acid given as enteral or parenteral nutritional intervention against sensorimotor and cognitive deficits in a mouse model of ischemic stroke.

  2016cites this paper
• Behavioral Testing in Rodent Models of Stroke, Part I

  2016cites this paper
• Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases

  2015cites this paper
• Adding 5 h delayed xenon to delayed hypothermia treatment improves long-term function in neonatal rats surviving to adulthood

  2015cites this paper
• Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase–Nicotinamide Adenine Dinucleotide Cascade

  2015cites this paper
• Transient but not permanent benefit of neuronal progenitor cell therapy after traumatic brain injury: potential causes and translational consequences

  2014influential citation
• A Method for Generate a Mouse Model of Stroke: Evaluation of Parameters for Blood Flow, Behavior, and Survival

  2014cites this paper
• Long-term functional recovery and compensation after cerebral ischemia in rats

  2014cites this paper
• New Avenues for Treatment of Intracranial Hemorrhage

  2013cites this paper
• PPARs: a potential target for a disease-modifying strategy in stroke.

  2013cites this paper
• Prevention of JNK Phosphorylation as a Mechanism for Rosiglitazone in Neuroprotection after Transient Cerebral Ischemia: Activation of Dual Specificity Phosphatase

  2013cites this paper
• Assessing Post-Stroke Behavior in Mouse Models of Focal Ischemia

  2013cites this paper
• Neonatal diethylstilbestrol exposure alters the metabolic profile of uterine epithelial cells

  2012cites this paper
• Essential role of interleukin-6 in post-stroke angiogenesis.

  2012cites this paper
• Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.

  2012influential citation
• Protective action of mithramycin against neurodegeneration and impairment of synaptic plasticity in the hippocampal CA1 area after transient global ischemia.

  2012cites this paper
• Neuroprotection by dietary restriction and the PPAR transcription complex

  2012cites this paper
• Expression Pattern of Peroxisome Proliferator-Activated Receptors in Rat Hippocampus following Cerebral Ischemia and Reperfusion Injury

  2012cites this paper
• Peroxisome proliferator‐activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo

  2011cites this paper
• Inflammatory Responses and Regulation in Parkinson’s Disease

  2011cites this paper
• TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice.

  2011cites this paper
• NEUROPROTECTIVE EFFECTS OF PIOGLITAZONE IN A RAT MODEL OF PERMANENT FOCAL CEREBRAL ISCHEMIA ARE ASSOCIATED WITH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA-MEDIATED SUPPRESSION OF NUCLEAR FACTOR-B SIGNALING

  2011influential citation
• The emergence of designed multiple ligands for neurodegenerative disorders.

  2011cites this paper
• Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.

  2011cites this paper
• A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke.

  2011cites this paper
• Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, induces dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels.

  2011cites this paper
• Multimodal drugs and their future for Alzheimer's and Parkinson's disease.

  2011cites this paper
• Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes

  2011cites this paper
• Behavioral Testing in Mouse Models of Stroke

  2010cites this paper
• Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre‐clinical systematic review

  2010cites this paper
• Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents.

  2010cites this paper
• D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.

  2010cites this paper
• Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET.

  2010cites this paper
• Characterization of the Netrin/RGMa receptor neogenin in neurogenic regions of the mouse and human adult forebrain

  2010cites this paper
• Neonatal diethylstilbestrol exposure alters the metabolic profile of Neonatal diethylstilbestrol exposure alters the metabolic profile of uterine epithelial cells uterine epithelial cells

  year unknowncites this paper